Vantin and Norvasc drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vantin (cefpodoxime proxetil) and Norvasc (amlodipine besylate). Common drug interactions include dyspnoea among females and venoocclusive liver disease among males.
The phase IV clinical study analyzes what interactions people have when they take Vantin and Norvasc. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Vantin?
Vantin has active ingredients of cefpodoxime proxetil. It is often used in sinusitis. eHealthMe is studying from 788 Vantin users. Check the latest studies of Vantin.
What is Norvasc?
Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.
35 people who take Vantin and Norvasc together, and have interactions are studied.

What are the common drug interactions of Vantin and Norvasc, by gender? *:
female:
- Dyspnoea (difficult or laboured respiration)
- Pneumonia
- Anaemia (lack of blood)
- Thrombocytopenia (decrease of platelets in blood)
- Abdominal pain upper
- Asthenia (weakness)
- Fatigue (feeling of tiredness)
- Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
- Chest pain
- Failure to thrive (inadequate weight gain and physical growth in children)
male:
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Chronic kidney disease
- Death
- Depression
- Diarrhoea
- Emotional distress
- Facial bones fracture (bone fracture of face)
- Fall
- Fear
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
What are the common drug interactions of Vantin and Norvasc, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Death
40-49:
- Renal failure (kidney dysfunction)
- Anxiety
- Chronic kidney disease
- Depression
- Emotional distress
- Fear
- Pain
- Renal impairment (severely reduced kidney function)
- Renal injury (kidney injury)
- Stress
50-59:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Pneumonia
60+:
- Dyspnoea (difficult or laboured respiration)
- Anaemia (lack of blood)
- Neutropenia (an abnormally low number of neutrophils)
- Pleural effusion (water on the lungs)
- Renal failure (kidney dysfunction)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Acute respiratory distress syndrome
- Arthralgia (joint pain)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bradycardia (abnormally slow heart action)
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 9 people, 25.71%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 17.14%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 17.14%
- Pain: 6 people, 17.14%
- Oral Candidiasis (fungal infection of mouth): 6 people, 17.14%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 17.14%
- Constipation: 5 people, 14.29%
- Nausea (feeling of having an urge to vomit): 4 people, 11.43%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 11.43%
- Bone Marrow Conditioning Regimen: 3 people, 8.57%
* Approximation only. Some reports may have incomplete information.
Do you take Vantin and Norvasc?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vantin and Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Norvasc and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefpodoxime proxetil and amlodipine besylate (the active ingredients of Vantin and Norvasc, respectively), and Vantin and Norvasc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Gilenya cause Erythema Multiforme? - 2 seconds ago
- Gastritis and Retching - 6 seconds ago
- Pneumonia Aspiration and Drug Level Decreased - 17 seconds ago
- Could Adalat cause Colon Cancer? - 19 seconds ago
- Drug interactions of Extavia and Glatopa - 36 seconds ago
- Could Exforge Hct cause Rashes? - 39 seconds ago
- Could Evista cause Belching? - 55 seconds ago
- Could Lipitor cause Inappropriate Affect? - a minute ago
- Thrombosis and Restless Leg Syndrome - a minute ago
- Could Eloxatin cause Diabetic Ketoacidosis? - a minute ago